Last week, presidential hopeful Hillary Clinton unveiled a series of proposals designed to rein in the high cost of prescription medicine. However, many of these cost-saving measures have been touted previously, and even if Clinton does win the presidential election, it’s still years before these policies could affect drug spending.
Instead of waiting, the FDA could help lower drug prices if it prioritizes the approval of generic drugs in its backlog based on the price (and the pace of recent price increases) for the brand-name drug the generic drug would compete against…
Comment:*
Nickname*
E-mail*
Website
Save my name, email, and website in this browser for the next time I comment.